SRX 0.00% 17.5¢ sierra rutile holdings limited

ASCO, page-17

  1. 973 Posts.
    lightbulb Created with Sketch. 25
    Looking at those results, common sense suggests that sir-spheres should be included in first line therapy for those whose cancer has only spread to the liver. An additional 7.9 months of progression free survival in the liver.
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.